Abstract
The objective of this prospective study was to assess patient exposure to the psychiatric use of unscheduled medications at all nine Pennsylvania state hospitals and to unify practice guidelines in this regard. In August 2004, a decision was made to discontinue the use of p.r.n. orders for psychiatric indications. All unscheduled medications, (p.r.n. and STAT physician’s order) administered for psychiatric indications were entered into a uniform database. A total of 46,913 unscheduled medications were administered to people served in the hospital system throughout this 15 month study. During March 2004, 87.7 unscheduled medications per 1,000 days-of-care were administered in the hospital system. During the last month of this study, May 2005, this rate had decreased to 17 per 1,000 days-of-care. Many hospital safety measures significantly improved as a result of this change. Cessation of p.r.n. medication use for psychiatric indications has significantly decreased patient exposure to unnecessary psychotropic medications and has resulted in a safer hospital system.
Similar content being viewed by others
References
Allentown State Hospital. (2000). Pennsylvania Medication Algorithm Project for Schizophrenia Procedure Guide. Allentown, Pennsylvania.
Allentown State Hospital. (2005). Pennsylvania Office of Mental Health and Substance Abuse Services Bulletin; Unscheduled Use of Medication in the State Hospital System: PRN & STAT Medication Orders, SMH-05-02, 1–2. Allentown, Pennsylvania.
Allentown State Hospital. (2006). Pennsylvanian Community Hospital Integration Projects Program. Allentown, Pennsylvania.
Ayd, F. J. (1985). Problems with orders for medication as needed. American Journal of Psychiatry, 142, 939–942.
Brown, C. R. (1978). The use of benzodiazepines in prison populations. Journal of Clinical Psychiatry 39, 219–222.
Craig, T. J., & Bracken, J. (1995). An epidemiological study of prn/stat medication use in a state psychiatric hospital. Annals of Clinical Psychiatry, 7, 57–64.
Craven, J. L., Voore, P. M., & Voineskos, G. (1987). PRN medication for psychiatric inpatients. Canadian Journal of Psychiatry 32, 199–203.
Geffen, J., Cameron, A., Sorensen, L., Stokes, J., Roberts, M., & Geffen, L. (2002). Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nurses [Electronic version]. Australian and New Zealand Journal of Psychiatry, 36, 642–648.
Mason, A. S., & Dewolfe, A. S. (1974). Usage of psychotropic drugs in a mental hospital: as needed (p.r.n.) antipsychotic medications. Current Therapeutic Research, 16, 853–860.
Mylan Pharmaceuticals Inc. (2004a). Clonazepam tablets, USP, [Brochure]. Morgantown, West Virginia: No Author.
Mylan Pharmaceuticals Inc. (2004b). Haloperidol tablets, USP, [Brochure]. Morgantown, West Virginia: No Author.
Mylan Pharmaceuticals Inc. (2004c). Lorazepam tablets, USP, [Brochure]. Morgantown, West Virginia: No Author.
Osher, F. C., & Drake, R. E. (1996). Reversing a history of unmet needs: approaches to caring for persons with co-occurring addictive mental disorders. American Journal of Orthopsychiatry, 66, 4–11.
Paton, C. (2002). Benzodiazepines and disinhibition: a review. Psychiatric Bulletin, 26, 460–462.
Salzman, C., Solomon, D., Miyawaki, E., Glassman, R., Rood, L., Flowers, C., et al. (1991). Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. Journal of Clinical Psychiatry, 52, 177–180.
Smith, G. M., Davis, R. H., Bixler, E., Lin, H., Altenor, A., Altenor, R., et al. (2005). Pennsylvania State Hospital system's seclusion and restraint reduction program. Psychiatric Services, 56, 1115–1122.
Sullivan, G. (1994). Factors influencing pain management-a nursing perspective. Journal of Post Anaesthetic Nursing, 9, 83–98.
Szczesny, S., & Miller, M. (2003). PRN medication use in inpatient psychiatry. Journal of Psychosocial Nursing & Mental Health Services, 41, 1321–1330.
Thapa, P., Palmer, S., Owen, R., Huntley, A., Clardy, J., & Miller, L. (2003). P.R.N. (as-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications [Electronic version]. Psychiatric Services, 5, 1282–1286.
Upsher-Smith Laboratories, Inc. (2004). Chlorpromazine hydrochloride tablets, USP, [Brochure]. Minneapolis, Minnesota: No Author.
Usher, K., Lidnsay, D., & Sellen, J. (2001). Mental health nurses' PRN pscyhotropic medication administration practices. Journal of Psychiatric and Mental Health Nursing, 8, 383–390.
Workman, D., & Cunningham, D. (1975). Effect of psychotropic drugs on aggression in a prison setting. Canadian Family Physician, November, 63–66.
Acknowledgements
The authors wish to recognize the work of William H. Steinmetz, BS, for his invaluable assistance with this project and the contributions of Donna Ashbridge, MS, RN and Debra Boyd, M.Ed. The authors also thank the Honorable Estelle B. Richman, MS, Secretary, Pennsylvania Department of Public Welfare, Joan L. Erney, JD, Deputy Secretary, Office of Mental Health & Substance Abuse Services for their support of this transformational initiative. Finally, the authors gratefully acknowledge the work and vision of Richard M. O’Dea, MS, RN.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, G.M., Davis, R.H., Altenor, A. et al. Psychiatric Use of Unscheduled Medications in the Pennsylvania State Hospital System: Effects of Discontinuing the Use of P.R.N. Orders. Community Ment Health J 44, 261–270 (2008). https://doi.org/10.1007/s10597-008-9126-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-008-9126-y